Skip to main content

Advertisement

Log in

Clinical features and prognoses of 23 patients with chronic granulomatous disease followed for 21 years by a single hospital in Japan

  • Original Paper
  • Published:
European Journal of Pediatrics Aims and scope Submit manuscript

Abstract

In this paper, we examined the details of severe infections, treatment efficacies, and the prognoses of 23 Japanese patients with chronic granulomatous disease (CGD). We described the mean ages at diagnosis and follow-up, which were 2.8 years (range, 0.7–10 years) and 14.9 years (range, 0.2–28.4 years), respectively. There were three deaths, two from Aspergillus pneumonia and one from liver abscess. Eighteen of the 23 patients (78%) had a complete loss of gp91phox, and three had p22-phox and one had p67phox deficiencies. Aspergillus species were found in 45% of 174 severe infections. The mean height and weight of the 20 surviving patients were −0.8 ± 1.3SD and −1.9 ± 1.9SD below the means for age, respectively. Short stature and underweight (below the 10th percentile of the means) for age were seen in 22% and 17% of the patients, respectively. This growth retardation reflects the severity of the disease. At 20 years of age, there was 87% survival. Ongoing prophylaxis with trimethoprim-sulfamethoxazole (TMP-SMX) or antifungal drugs was given in 16 and 11 patients, respectively. Interferon-gamma (IFN-gamma) was given once a week to 14 patients. Four patients underwent hematopoietic stem cell transplantation (HSCT) and are currently well. There were infections observed in three of 21 identified related carriers of X-linked CGD. A carrier with a liver abscess had 5% normal neutrophils during the acute phase of infection, which returned to 40% normal neutrophils after recovery. The high survival rate in this hospital results from regular follow-up and prophylaxis with TMP-SMX and anti-fungal drugs beginning at the time of diagnosis, along with treatment with weekly IFN-gamma.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

Abbreviations

CGD:

chronic granulomatous disease

DHR:

dihydrorhodamine123

TMP-SMX:

trimethoprim-sulfamethoxazole

IFN-gamma:

interferon-gamma

SD:

standard deviation

HSCT:

hematopoietic stem cell transplantation

References

  1. Aliabadi H, Gonzalez R, Quie PG (1989) Urinary tract disorders in patients with chronic granulomatous disease. N Engl J Med 321:706–708

    Article  PubMed  CAS  Google Scholar 

  2. Berendes H, Bridges RA, Good RA (1957) A fatal granulomatosus of childhood: the clinical study of a new syndrome. Minn Med 40:309–312

    PubMed  CAS  Google Scholar 

  3. Bridges RA, Berendes H, Good RAA (1959) A fatal granulomatous disease of childhood: the clinical, pathological, and laboratory features of a new syndrome. Am J Dis Child 97:387–408

    CAS  Google Scholar 

  4. Curnutte JT (1993) Chronic granulomatous disease: the solving of a clinical riddle at the molecular level. Clin Immunol Immunopath 67:S2–S15

    Article  CAS  Google Scholar 

  5. Dickerman JD, Colletti RB, Tampas JP (1986) Gastric outlet obstruction in chronic granulomatous disease of childhood. Am J Dis Child 140(6):567–570

    PubMed  CAS  Google Scholar 

  6. Güngör T, Halter J, Klink A, Junge S, Stumpe KD, Seger R, Schanz U (2005) Successful low toxicity hematopoietic stem cell transplantation for high-risk adult chronic granulomatous disease patients. Transplantation 79:1596–1606

    Article  PubMed  Google Scholar 

  7. Hasui M; The Study Group of Phagocyte Disorders of Japan (1999) Chronic granulomatous disease in Japan: incidence and natural history. Pediatr Int 41:589–593

    Article  PubMed  CAS  Google Scholar 

  8. The International Chronic Granulomatous Disease Cooperative Study Group (1991) A controlled trial of interferon gamma to prevent infection in chronic granulomatous disease. N Engl J Med 324:509–516

    Article  Google Scholar 

  9. Johnson FE, Humbert JR, Kuzela DC, Todd JK, Lilly JR (1975) Gastric outlet obstruction due to X-linked chronic granulomatous disease. Surgery 78(2):217–223

    PubMed  CAS  Google Scholar 

  10. Kamani N, August CS, Douglas SD, Burkey E, Etzioni A, Lischner HW (1984) Bone marrow transplantation in chronic granulomatous disease. J Pediatr 105:42–46

    Article  PubMed  CAS  Google Scholar 

  11. Liese J, Kloos S, Jendrossek V, Petropoulou T, Wintergerst U, Notheis G, Gahr M, Belohradsky BH (2000) Long-term follow-up and outcome of 39 patients with chronic granulomatous disease. J Pediatr 137:687–693

    Article  PubMed  CAS  Google Scholar 

  12. Marciano BE, Wesley R, De Carlo ES, Anderson VL, Barnhart LA, Darnell D, Malech HL, Gallin JI, Holland SM (2004) Long-term interferon-gamma therapy for patients with chronic granulomatous disease. Clin Infect Dis 39:692–699

    Article  PubMed  CAS  Google Scholar 

  13. Margolis DM, Melnick DA, Alling DW, Gallin JI (1990) Trimethoprim-sulfamethoxazole prophylaxis in the management of chronic granulomatous disease. J Infect Dis 162:723–726

    PubMed  CAS  Google Scholar 

  14. Mizukami T, Nunoi H (2004) Chronic granulomatous disease. Progress of basic science and clinical management (in Japanese). Nihon Shouniketueki Gakkaishi 18:69–78

    Google Scholar 

  15. Mouy R, Veber F, Blanche S, Donadieu J, Brauner R, Levron JC, Griscelli C, Fischer A (1994) Long-term itraconazole prophylaxis against Aspergillus infections in thirty-two patients with chronic granulomatous disease. J Pediatr 125:998–1003

    Article  PubMed  CAS  Google Scholar 

  16. Pasic S, Minic A, Minic P, Veljkovic D, Lilic D, Slavkovic B, Pejnovic N, Abinun M (2003) Long-term follow-up and prognosis of chronic granulomatous disease in Yugoslavia: is there a role for early bone marrow transplantation? J Clin Immunol 23(1):55–61

    Article  PubMed  CAS  Google Scholar 

  17. Rösen-Wolff A, Soldan W, Heyne K, Bickhardt J, Gahr M, Roestler J (2001) Increased susceptibility of a carrier of X-linked chronic granulomatous disease (CGD) to Aspergillus fumigatus infection associated with age-related skewing of lyonization. Ann Hematol 80:113–115

    Article  PubMed  Google Scholar 

  18. Segal BH, Leto TL, Gallin JI, Malech HL, Holland SM (2000) Genetic, biochemical, and clinical features of chronic granulomatous disease. Medicine (Baltimore) 79(3):170–200

    Article  CAS  Google Scholar 

  19. Seger RA, Gungor T, Belohradsky BH, Blanche S, Bordigoni P, Di Bartolomeo P, Flood T, Landais P, Müller S, Ozsahin H, Passwell JH, Porta F, Slavin S, Wulffraat N, Zintl F, Nagler A, Cant A, Fischer A; European Group for Blood and Marrow Transplantation (2002) Treatment of chronic granulomatous disease with myeloablative conditioning and an unmodified hemopoietic allograft: a survey of the European experience, 1985–2000. Blood 100:4344–4350

    Article  PubMed  CAS  Google Scholar 

  20. Winkelstein JA, Marino MC, Johnston RB Jr, Boyle J, Curnutte J, Gallin JI, Malech HL, Holland SM, Ochs H, Quie P, Buckley RH, Foster CB, Chanock SJ, Dickler H (2000) Chronic granulomatous disease. Report on a national registry of 368 patients. Medicine 79:155–169

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Shinichi Kobayashi.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kobayashi, S., Murayama, S., Takanashi, S. et al. Clinical features and prognoses of 23 patients with chronic granulomatous disease followed for 21 years by a single hospital in Japan. Eur J Pediatr 167, 1389–1394 (2008). https://doi.org/10.1007/s00431-008-0680-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00431-008-0680-7

Keywords

Navigation